Journal of Neuroscience Nursing - Intrathecal baclofen therapy: ten steps toward best practice.
November 19th, 2008 Most Popular
5 Regular Mistakes In Public Speaking
Public Speaking: 7 Secrets Of Great Public Speakers
13 Job Interview Mistakes To Avoid
10 Jobs That Pay $30 An Hour
3 Questions No Job Seeker Ever Wants To Be Asked?
> Abstract: Practitioners from around the country …
Australian Doctor - Balancing act.(general practice regulations)
November 13th, 2008John Kron
It’s the bane of doctors’ lives, but is there a legitimate place for red tape?
IT was an anxious wait for Dr Warwick Carter. He received a phone call from the PBS saying his prescribing profile was ‘grossly abnormal’ and he was to receive a visit from a PBS official the following week.
In the ensuing days Dr Carter, a GP in Sumner Park, Queensland, racked his worried mind trying to identify what was abnormal about his prescrib…
American Journal of Critical Care - An initially unsuspected case of baclofen overdose
November 9th, 2008Baclofen, a derivative of [gamma]-aminobutyric acid, is used for symptomatic relief of skeletal muscle spasm and spasticity, particularly in patients with multiple sclerosis. (1) Although its exact mechanism is not fully understood, its main effects at the spinal end of upper motor neurons are thought to cause muscle relaxation. Adverse effects of baclofen a…
Market Wire - AGI Therapeutics plc announces key findings of clinical PK study of arbaclofen (AGI-006)
November 7th, 2008AGI announces key findings of clinical PK study of arbaclofen (AGI-006)
Dublin, Ireland, 2 April 2008 - AGI Therapeutics plc (”AGI” or the “Company”)
(AIM, IEX: AGI), a speciality pharmaceutical company focused on gastrointestinal
drug products, today announces the key…
Journal of Bone and Joint Surgery - PLACE OF INTRATHECAL BACLOFEN TEST FOR ASSESSING NEURO-ORTHOPAEDIC COMPLICATIONS INVOLVING RETRACTION OF THE LOWER LIMBS
November 4th, 2008Purpose: Multiple deformations of the lower limbs are common orthopaedic complications of central nervous system disease. Assessment is difficult. Intrathecal Lioresal was proposed for the patients to establish the relative effects of spasticity and musculo-tendi…
Journal of Neurologic Physical Therapy - Intrathecal Baclofen: A New Treatment Approach for Severe Spasticity in Patients with Stroke
November 2nd, 2008ABSTRACT
Intrathecal baclofen (ITB) is a relatively new treatment approach that may be useful for treating spasticity in patients with chronic stroke. In this paper, we examine ITB treatment of spastieity caused by stroke and the implications for physical therapy man…
JCNN News Summaries - Japan Corporate News Network - Daiichi Products Covered by National Health Insurance
October 27th, 2008 Tokyo, Apr 5, 2006 - (JCN) - Some of Daiichi Pharmaceutical’s Intrathecal Baclofen therapy products are now listed for national health insurance reimbursement. One of them is the SynchroMed infusion system that comprises of the SynchroMed EL pump and the InDura catheter.
Intrathecal Gabalon (baclofen) and the SynchroMed system are used to treat severe spasticity in patients if conventional treatments don’t. The system i…
Internal Medicine News - Baclofen Reduces Symptoms of Duodenogastroesophageal Reflux.
October 21st, 2008 ATLANTA — Baclofen inhibits transient lower esophageal sphincter relaxations associated with duodenogastroesophageal reflux, Dr. Geert Koek said at the annual Digestive Disease Week.
According to Dr. Geert Koek of Catholic University, Leuven, Belgium, duodenogastroesophageal reflux disease is differentiated from gastroesophageal reflux disease by significant amounts of refluxed bile from the duodenum. Patients can have persist…
Business Wire - Lannett Receives Approval to Market Baclofen 10mg Tablets
October 16th, 2008 New Dosage Expands Sales Reach
PHILADELPHIA — Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Baclofen 10mg tablets, bolstering the company’s existing product offering of Baclofen 20mg tablets.
Total U.S. annual sales as of May 2007 for Baclofen 10mg were $153 million and $108 million for Baclofen 20mg, accordin…
Bandolier - Intrathecal baclofen for severe spasticity
October 12th, 2008Health service purchasers are often faced with the problem of making decisions in the absence of evidence on benefit and cost. Evidence is most often lacking in rare but severe conditions, and in early applications of new technology. The example of intrathecal baclofen for severe spasticity [1] shows that even in these difficult circumstances sufficient evidence may be garnered…


